Search - tctmd.com

Displaying 761 - 780 of 1179

Sort: Relevancy | Date

Presentation

Clinical outcomes associated with dual antiplatelet therapy interruption following implantation of the ResoluteTM zotarolimus-eluting stent

Presenter: Martin T. Rothman

December 01, 2013

News Conference News AHA 2013

STREAM: Pre-hospital Fibrinolysis Strategy as Safe as Primary PCI at 1 Year in STEMI

Yael L. Maxwell

November 18, 2013

News Conference News AHA 2013

Two Trials Look at Therapeutic Hypothermia in Out-of-Hospital Cardiac Arrest Patients

Yael L. Maxwell

November 16, 2013

News Conference News AHA 2013

Long-term Outcomes with Renal Denervation Show Sustained Benefit

Yael L. Maxwell

November 16, 2013

News Conference News TCT 2013

Triple Antiplatelet Therapy with Cilostazol Increases Tachycardia, Arrhythmias

November 04, 2013

News Daily News

HORIZONS-AMI: Mortality Reduction with Bivalirudin Only Partially Due to Bleeding

Caitlin E. Cox

November 01, 2013

Presentation TCT 2013

Platelet Function Testing is of Clear Clinical Utility in Selected Patients

Presenter: Paul Gurbel

October 31, 2013

Presentation TCT 2013

The DAPT Duration Dilemma: Recent Trials and Reasonable Guidelines for Clinical Practice

Presenter: Dean Kereiakes

October 31, 2013

Presentation TCT 2013

Genetic Testing is of Clear Clinical Utility in Selected Patients

Presenter: Jessica Mega

October 31, 2013

Presentation TCT 2013

Critical Appraisal and Clinical Implications(3)

Presenter: Dean Kereiakes

October 31, 2013

Presentation

Pharmacology in High-Risk PCI: Focus on Clinical Outcomes

Presenter: C. Michael Gibson

October 31, 2013

News Conference News TCT 2013

Studies Find Differing Benefits of Platelet, Genotype Testing

October 31, 2013

News Conference News TCT 2013

OPTIMIZE: 3-Month DAPT Safe with ZES

October 31, 2013

Presentation TCT 2013

EUROMAX: Critical Appraisal and Clinical Implications

Presenter: Gregg Stone

October 30, 2013

Presentation TCT 2013

The Ongoing Saga of Short DAPT Therapy After DES: Navigating Device Evolution, New Pharmacotherapy, and Changing Clinical Practice Standards

Presenter: Roxana Mehran

October 30, 2013

Presentation TCT 2013

Expanding Clinical Indications: Moderate Hypertension and Replacing (vs. Supplementing) Medical Pharmacotherapy

Presenter: Krishna Rocha-Singh

October 30, 2013

News Conference News TCT 2013

Two Studies Examine Two-Stent Strategy vs. Provisional Stenting in Coronary Bifurcation Lesions

October 30, 2013

News Conference News TCT 2013

Need, Potential Exist for Global Integrated Regulatory Approach in Cardiology

October 30, 2013

News Conference News TCT 2013

EUROMAX: Prehospital Bivalirudin Reduces Bleeding in STEMI

October 30, 2013

News Conference News TCT 2013

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

October 30, 2013

Advertisement

Clinical outcomes associated with dual antiplatelet therapy interruption following implantation of the ResoluteTM zotarolimus-eluting stent

STREAM: Pre-hospital Fibrinolysis Strategy as Safe as Primary PCI at 1 Year in STEMI

Two Trials Look at Therapeutic Hypothermia in Out-of-Hospital Cardiac Arrest Patients

Long-term Outcomes with Renal Denervation Show Sustained Benefit

Triple Antiplatelet Therapy with Cilostazol Increases Tachycardia, Arrhythmias

HORIZONS-AMI: Mortality Reduction with Bivalirudin Only Partially Due to Bleeding

Platelet Function Testing is of Clear Clinical Utility in Selected Patients

The DAPT Duration Dilemma: Recent Trials and Reasonable Guidelines for Clinical Practice

Genetic Testing is of Clear Clinical Utility in Selected Patients

Critical Appraisal and Clinical Implications(3)

Pharmacology in High-Risk PCI: Focus on Clinical Outcomes

Studies Find Differing Benefits of Platelet, Genotype Testing

OPTIMIZE: 3-Month DAPT Safe with ZES

EUROMAX: Critical Appraisal and Clinical Implications

The Ongoing Saga of Short DAPT Therapy After DES: Navigating Device Evolution, New Pharmacotherapy, and Changing Clinical Practice Standards

Expanding Clinical Indications: Moderate Hypertension and Replacing (vs. Supplementing) Medical Pharmacotherapy

Two Studies Examine Two-Stent Strategy vs. Provisional Stenting in Coronary Bifurcation Lesions

Need, Potential Exist for Global Integrated Regulatory Approach in Cardiology

EUROMAX: Prehospital Bivalirudin Reduces Bleeding in STEMI

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content